Schedule 2 Capital fees for applications for, and variations to, marketing authorisations, licences, registrations and certificatesF1
Repealed
- 1General: interpretation and categories of applications and variations
- 2Capital Fees for Applications for Authorisations, Licences, Registrations and Certificates
- 3Capital Fees for Assistance in Obtaining Marketing Authorisations in Other EEA States
- 4Capital Fees for Applications for Variations of Authorisations, Licences and Registrations
- 5Capital Fees for Assessment of Labels and Leaflets
- 6Capital Fees for Regulatory Assistance Given by the United Kingdom Acting as Reference Member State Relating to the Assessment of Applications for the Renewal of Specified Marketing Authorisations
- 7Relevant Substances
Annotations
Textual amendments
- F1
Regulations revoked (1.4.2016) by The Medicines (Products for Human Use) (Fees) Regulations 2016 (S.I. 2016/190), reg. 63(1) (with reg. 63(2)-(4))